Phase 1b study of dazostinag plus pembrolizumab after hypofractionated radiotherapy in patients with non-small-cell lung cancer, triple-negative breast cancer, or head and neck squamous-cell carcinoma
Publication Title
SITC Annual Meeting; November 6-10; Houston, TX 2024: 778
Document Type
Abstract
Publication Date
11-1-2024
Keywords
oregon; chiles
Area of Special Interest
Cancer
Area of Special Interest
Neurosciences (Brain & Spine)
Area of Special Interest
Women & Children
Specialty/Research Institute
Oncology
Specialty/Research Institute
Neurosciences
Comments
Cooper BT, Olson D, Iams WT, Page DB, Yuan Y, M.K. G, Gibbs J, Gregory RC, Wong K-K, Deng J, Perera SA, Ding K, Roberts ER, Berger A, Christensen Ross CL, Tong EX, Maldonado Lopez AE, Appleman VA, Leonard EJ, Parent A, Huang HC-H, Bay C, Li C, Lineberry N, Raizer J, Chmura SJ